Skip to main content

Table 3 Value of lncRNA-ANRIL single detection, SOX9 single detection, and the combined detection for the early diagnosis of glioma

From: Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

 

lncRNA-ANRIL

SOX9

Combined detection

Cut-off

2.018

0.395

0.388

Sensitivity (%)

61.97

69.72

81.62

Specificity (%)

96.67

85.00

90.83

AUC

0.860

0.857

0.930

95%CI

91.69–99.08%

77.33–90.86%

84.19–95.33%

Std. error

0.023

0.022

0.016

P

<0.001

<0.001

<0.001